GP-Act III Acquisition Corp. $GPAT Shares Sold by Commonwealth of Pennsylvania Public School Empls Retrmt SYS

Commonwealth of Pennsylvania Public School Empls Retrmt SYS cut its holdings in shares of GP-Act III Acquisition Corp. (NASDAQ:GPATFree Report) by 86.9% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 53,900 shares of the company’s stock after selling 358,364 shares during the quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS’s holdings in GP-Act III Acquisition were worth $584,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also recently modified their holdings of GPAT. TENOR CAPITAL MANAGEMENT Co. L.P. acquired a new position in GP-Act III Acquisition in the second quarter valued at about $7,800,000. L1 Global Manager Pty Ltd purchased a new stake in shares of GP-Act III Acquisition in the 4th quarter valued at approximately $6,067,000. Westchester Capital Management LLC lifted its holdings in shares of GP-Act III Acquisition by 22.5% in the 4th quarter. Westchester Capital Management LLC now owns 1,360,852 shares of the company’s stock worth $14,561,000 after acquiring an additional 250,000 shares during the last quarter. JPMorgan Chase & Co. acquired a new position in shares of GP-Act III Acquisition in the 2nd quarter worth approximately $2,377,000. Finally, Meteora Capital LLC lifted its holdings in shares of GP-Act III Acquisition by 62.8% in the 4th quarter. Meteora Capital LLC now owns 408,719 shares of the company’s stock worth $4,369,000 after acquiring an additional 157,689 shares during the last quarter.

GP-Act III Acquisition Stock Up 1.0%

NASDAQ GPAT opened at $11.12 on Friday. The stock has a 50-day moving average of $10.94 and a two-hundred day moving average of $10.84. GP-Act III Acquisition Corp. has a 1-year low of $10.50 and a 1-year high of $12.00.

GP-Act III Acquisition (NASDAQ:GPATGet Free Report) last announced its quarterly earnings data on Thursday, May 14th. The company reported $0.06 earnings per share for the quarter.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reiterated a “sell (d)” rating on shares of GP-Act III Acquisition in a report on Tuesday, April 21st. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company currently has a consensus rating of “Sell”.

Check Out Our Latest Stock Report on GP-Act III Acquisition

About GP-Act III Acquisition

(Free Report)

GP-Act III Acquisition Corp is a special purpose acquisition company organized as a Delaware corporation that completed its initial public offering in 2021. As a blank-check company, it has no commercial operations of its own and was formed to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

The company’s primary business activity is to identify and acquire a target company in sectors such as technology, business services, healthcare or other high-growth industries.

Read More

Want to see what other hedge funds are holding GPAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GP-Act III Acquisition Corp. (NASDAQ:GPATFree Report).

Institutional Ownership by Quarter for GP-Act III Acquisition (NASDAQ:GPAT)

Receive News & Ratings for GP-Act III Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GP-Act III Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.